Increased transcription of ubiquitin-proteasome system components: Molecular responses associated with muscle atrophy

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 5, 2003, Pages 617-628

  Price, S R ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Cachexia; Glucocorticoids; Proteasome; Protein degradation; Skeletal muscle; Ubiquitin

Indexed keywords

ATROGIN 1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; I KAPPA B; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MIFEPRISTONE; MITHRAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEASOME; PROTEIN; PROTEIN MURF1; PROTEIN SUBUNIT; TORBAFYLLINE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; UBIQUITIN; UNCLASSIFIED DRUG;

CACHEXIA; CATABOLISM; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; MUSCLE ATROPHY; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; TRANSACTIVATION;

EID: 0037401445     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00385-0     Document Type: Review

References (111)

1. Almawi W.Y., Melemedjian O.K. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. Journal of Molecular Endocrinology. 28:2002;69-78.
2. Alvarez B., Quinn L.S., Busquets S., Lopez-Soriano F.J., Argiles J.M. Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism. European Cytokine Network. 12:2001;399-410.
3. Attaix D., Combaret L., Pouch M.N., Taillandier D. Regulation of proteolysis. Current Opinion in Clinical and Nutrition Metabolism Care. 4:2001;45-49.
4. Auclair D., Garrel D.R., Zerouala A.C., Ferland L.H. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. American Journal of Physiology. 272:1997;C1007-C1016.
5. Bailey J.L., Wang X., England B.K., Price S.R., Ding X., Mitch W.E. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. Journal of Clinical Investigation. 97:1996;1447-1453.
6. Baker R.T., Board P.G. The human ubiquitin gene family: Structure of a gene and pseudogene from the Ub B subfamily. Nucleic Acids Research. 15:1987;443-463.
7. Baker R.T., Board P.G. Unequal crossover generates variation in the ubiquitin coding unit number at the human UbC polyubiquitin locus. American Journal of Human Genetics. 44:1989;534-542.
8. Baracos V.E. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia. Nutrition. 16:2000;1015-1018.
9. Baracos V.E., DeVivo C., Hoyle D.H.R., Goldberg A.L. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. American Journal of Physiology. 268:1995;E996-E1006.
10. Biolo G., Bosutti A., Iscra F., Toigo G., Gullo A., Guarnieri G. Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients. Metabolism. 49:2000;689-691.
11. Black A.R., Jensen D., Lin S.Y., Azizkhan J.C. Growth/cell cycle regulation of Sp1 phosphorylation. Journal of Biological Chemistry. 274:1999;1207-1215.
12. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 294:2001;1704-1708.
13. Bossola M., Muscaritoli M., Costelli P., Bellantone R., Pacelli F., Busquets S., Argiles J., Lopez-Soriano F.J., Civello I.M., Baccino F.M., Fanelli F.R., Doglietto G.B. Increased muscle ubiquitin mRNA levels in gastric cancer patients. American Journal of Physiology - Regulatory Integrative and Comprehensive Physiology. 280:2001;R1518-R1523.
14. Cato, A. C., Nestl, A., & Mink, S. (2002). Rapid actions of steroid receptors in cellular signaling pathways. Science's STKE, 138.
15. Centner T., Yano J., Kimura E., McElhinny A.S., Pelin K., Witt C.C., Bang M.L., Trombitas K., Granzier H., Gregorio C.C., Sorimachi H., Labeit S. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. Journal of Molecular Biology. 306:2001;717-726.
16. Chupreta S., Du M., Todisco A., Merchant J.L. EGF stimulates gastrin promoter through activation of Sp1 kinase activity. American Journal of Physiology - Cell Physiology. 278:2000;C697-C708.
17. Combaret L., Tilignac T., Claustre A., Voisin L., Taillandier D., Obled C., Tanaka K., Attaix D. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats. Biochemistry Journal. 361:2002;185-192.
18. Costelli P., Carbó N., Tessitore L., Bagby G.J., Lopez-Soriano F.J., Argilés J.M., Baccino F.M. Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model. Journal of Clinical Investigation. 92:1993;2783-2789.
19. Dardevet D., Sornet C., Taillandier D., Savary I., Attaix D., Grizard J. Sensitivity and protein turnover response to glucocortiocoids are different in skeletal muscle from adult and old rats: Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. Journal of Clinical Investigation. 96:1995;2113-2119.
20. Desler M.M., Jones S.J., Smith C.W., Woods T.L. Effects of dexamethasone and anabolic agents on proliferation and protein synthesis and degradation in C2C12 myogenic cells. Journal of Animal Science. 74:1996;1265-1273.
21. Du J., Mitch W.E., Wang X., Price S.R. Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-κB. Journal of Biological Chemistry. 275:2000;19661-19666.
22. Fang C.-H., James H.J., Ogle C., Fischer J.E., Hasselgren P.-O. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. Journal of American College of Surgery. 180:1995;161-170.
23. Fang C.-H., Li B.G., Sun X., Hasselgren P.-O. Insulin-like growth factor I reduces ubiquitin and ubiquitin-conjugating enzyme gene expression but does not inhibit muscle proteolysis in septic rats. Endocrinology. 141:2000;2743-2751.
24. Fischer D., Sun X., Gang G., Pritts T., Hasselgren P.-O. The gene expression of ubiquitin ligase E3alpha is up-regulated in skeletal muscle during sepsis in rats-potential role of glucocorticoids. Biochemical and Biophysics Research and Communication. 267:2000;504-508.
25. Flores E.A., Bistrian B.R., Pomposelli J.J., Cinarello C.A., Blackburn G.L., Istfan N.W. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. Journal of Clinical Investigation. 83:1989;1614-1622.
26. Fojas, de B., Collins, N. K., Du, P., Azizkhan-Clifford, J., & Mudryj, M. (2001). Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription, EMBO Journal, 20, 5737-5747.
27. Gambari R., Feriotto G., Rutigliano C., Bianchi N., Mischiati C. Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs. Journal of Pharmacology and Experimental Therapeutics. 294:2000;370-377.
28. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiology Review. 82:2002;373-428.
29. Gomes M.D., Lecker S.H., Jagoe R.T., Navon A., Goldberg A.L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proceedings of the National Academy of Sciences of the United States of America. 98:2001;14440-14445.
30. Goodman M.N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. American Journal of Physiology. 260:1991;E727-E730.
31. Hall-Angerås M., Angerås U., Zamir O., Hasselgren P.-O., Fischer J.E. Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis. Surgery. 108:1990;460-466.
32. Hasselgren P.-O. Glucocorticoids and muscle catabolism. Current Opinion in Clinical and Nutrition Metabolism Care. 2:1999;201-205.
33. Hasselgren P.-O., Wray C., Mammen J. Molecular regulation of muscle cachexia: It may be more than the proteasome. Biochemical and Biophysics Research and Communication. 290:2002;1-10.
34. Hobler S.C., Williams A., Fischer D., Wang J.-J., Sun X., Fischer J.E., Monaco J.J., Hasselgren P.-O. Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. American Journal of Physiology. 277:1999;R434-R440.
35. Hong D.-H., Forsberg N.E. Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures. Molecular and Cellular Endocrinology. 108:1995;199-209.
36. 3H1 myocytes require an interaction between glucocorticoids and acidification. Proceedings of the National Academy of Sciences of the United States of America. 97:1996;1967-1971.
37. Jagoe R.T., Goldberg A.L. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Current Opinion in Clinical and Nutrition Metabolism Care. 4:2001;183-190.
38. Jagoe R.T., Lecker S.H., Gomes M., Goldberg A.L. Patterns of gene expression in atrophying skeletal muscles: Response to food deprivation. FASEB Journal. 16:2002;1697-1712.
39. Karin M. New twists in gene regulation by glucocorticoid receptor: Is DNA binding dispensable? Cell. 93:1998;487-490.
40. Karin M., Chang L. AP-1 - glucocorticoid receptor cross-talk taken to a higher level. Journal of Endocrinology. 169:2001;447-451.
41. Konagaya M., Bernard P.A., Max S.R. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in rat by RU38486, a potent glucocorticoid antagonist. Endocrinology. 119:1986;375-380.
42. Kumar A.P., Butler A.P. Serum responsive gene expression mediated by Sp1. Biochemical and Biophysics Research and Communication. 252:1998;517-523.
43. Lecker S.H., Solomon V., Price S.R., Kwon Y.T., Mitch W.E., Goldberg A.L. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. Journal of Clinical Investigation. 104:1999;1411-1420.
44. Llovera M., García-Martínez C., Agell N., Marzábal M., Lopez-Soriano F.J., Argilés J.M. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Letters. 338:1994;311-318.
45. Llovera M., García-Martínez C., Agell N., Lopez-Soriano F.J., Argilés J.M. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochemical and Biophysics Research and Communication. 230:1997;238-241.
46. Llovera M., García-Martínez C., Lopez-Soriano J., Carbó N., Agell N., Lopez-Soriano F.J., Argilés J.M. Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice. Molecular and Cellular Endocrinology. 142:1998;183-189.
47. Llovera M., Garcia-Martinez C., Lopez-Soriano J., Agell N., Lopez-Soriano F.J., Garcia I., Argilés J.M. Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1. Cancer Letters. 130:1998;19-27.
48. Llovera M., Garcia-Martinez C., Agell N., Lopez-Soriano F.J., Authier F.J., Gherardi R.K., Argilés J.M. Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. International Journal of Molecular Medicine. 2:1998;69-73.
49. Llovera M., Carbó N., Lopez-Soriano J., García-Martínez C., Busquets S., Alvarez B., Agell N., Costelli P., Lopez-Soriano F.J., Celada A., Argilés J.M. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Letters. 133:1999;83-87.
50. Luo G., Sun X., Hungness E., Hasselgren P.-O. Heat shock protects L6 myotubes from catabolic effects of dexamethasone and prevents down-regulation of NF-kappaB. American Journal of Physiology - Regulatory Integrative and Comprehensive Physiology. 281:2001;R1193-R1200.
51. 2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;2714-2718.
52. Marinovic A.C., Mitch W.E., Price S.R. Tools for evaluating ubiquitin (UbC) gene expression: Characterization of the rat UbC promoter and use of an unique 3' mRNA sequence. Biochemical and Biophysics Research Communication. 274:2000;537-541.
53. Marinovic A.C., Zheng B., Mitch W.E., Price S.R. Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. Journal of Biological Chemistry. 277:2002;16673-16681.
54. Marquis K., Debigare R., Lacasse Y., LeBlanc P., Jobin J., Carrier G., Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 166:2002;809-813.
55. May R.C., Kelly R.A., Mitch W.E. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. Journal of Clinical Investigation. 77:1986;614-621.
56. McElhinny A.S., Kakinuma K., Sorimachi H., Labeit S., Gregorio C.C. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. Journal Cell Biology. 157:2002;125-136.
57. McKay L.I., Cidlowski J.A. Cross-talk between nuclear factor-κB and steroid hormone receptors: Mechanisms of mutual antagonism. Molecular Endocrinology. 12:1998;45-56.
58. Medina R., Wing S.S., Goldberg A.L. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochemistry Journal. 307:1995;631-637.
59. Mehrotra R., Kopple J.D. Nutritional management of maintenance dialysis patients: Why aren't we doing better? Annual Review of Nutrition. 21:2001;343-379.
60. Merchant J.L., Du M., Todisco A. Sp1 phosphorylation by ERK2 stimulates DNA binding. Biochemical and Biophysics Research and Communication. 254:1999;454-461.
61. Milanini-Mongiat J., Pouyssegur J., Pages G. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: Their implication in vascular endothelial growth factor gene transcription. Journal of Biological Chemistry. 277:2002;20631-20639.
62. Mitch W.E., Goldberg A.L. Mechanisms of muscle wasting: The role of the ubiquitin-proteasome pathway. New England Journal of Medicine. 335:1996;1897-1905.
63. Mitch W.E., Bailey J.L., Wang X., Jurkovitz C., Newby D., Price S.R. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. American Journal of Physiology. 276:1999;C1132-C1138.
64. Mitch W.E., Price S.R. Mechanisms activated by kidney disease and the loss of muscle mass. American Journal of Kidney Disease. 38:2001;1337-1342.
65. Mitch W.E., Medina R., Greiber S., Goldberg A.L. Accelerated muscle proteolysis in acidosis involves increased mRNA for ubiquitin and subunits of the proteosome (multicatalytic proteinase). FASEB Journal. 5:1991;3210.
66. Mitch W.E., Medina R., Greiber S., May R.C., England B.K., Price S.R., Bailey J.L., Goldberg A.L. Metabolic acidosis stimulates muscle protein degradation by activating the ATP-dependent pathway involving ubiquitin and proteasomes. Journal of Clinical Investigation. 93:1994;2127-2133.
67. Nenoi M., Mita K., Ichimura S., Cartwright I.L., Takahashi E.-I., Yamauchi M., Tsuji H. Hetergeneous structure of the polyubiquitin gene UbC of Hela S3 cells. Gene. 175:1996;179-185.
68. Odedra B.R., Millward D.J. Effect of corticosterone treatment on muscle protein turnover in adrenalectomized rats and diabetic rats maintained on insulin. Biochemistry Journal. 204:1982;663-672.
69. Ordway G.A., Neufer P.D., Chin E.R., DeMartino G.N. Chronic contractile activity up-regulates the proteasome system in rabbit skeletal muscle. Journal of Applied Physiology. 88:2000;1134-1141.
70. Parks C.L., Shenk T. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. Journal of Biological Chemistry. 271:1996;4417-4430.
71. Patel S.G., DiMario J.X. Two distal Sp1-binding cis-elements regulate fibroblast growth factor receptor 1 (FGFR1) gene expression in myoblasts. Gene. 270:2001;171-180.
72. Penner C.G., Gang G., Wray C., Fischer J.E., Hasselgren P.-O. The transcription factors NF-kappaB and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochemical and Biophysics Research and Communication. 281:2001;1331-1336.
73. Penner G., Gang G., Sun X., Wray C., Hasselgren P.-O. C/EBP DNA-binding activity is up-regulated by a glucocorticoid-dependent mechanism in septic muscle. American Journal of Physiology - Regulatory Integrative and Comprehensive Physiology. 282:2002;R439-R444.
74. Pickering W.P., Price S.R., Bircher G., Marinovic A.C., Mitch W.E., Walls J. Nutrition in CAPD: Serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney International. 61:2002;1286-1292.
75. Pisters P.W., Brennan M.F. Amino acid metabolism in human cancer cachexia. Annual Review of Nutrition. 10:1990;107-132.
76. Price S.R., England B.K., Bailey J.L., Van Vreede K., Mitch W.E. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs levels in rat muscle. American Journal of Physiology. 267:1994;C955-C960.
77. Price S.R., Bailey J.L., Wang X., Jurkovitz C., England B.K., Ding X., Phillips L.S., Mitch W.E. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent. Journal of Clinical Investigation. 98:1996;1703-1708.
78. Price S.R., Du J.D., Bailey J.L., Mitch W.E. Molecular mechanisms regulating protein turnover in muscle. American Journal of Kidney Disease. 37:2001;S112-S114.
79. Rafty L.A., Khachigian L.M. Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta. Nucleic Acids Research. 29:2001;1027-1033.
80. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. Journal of Experimental Medicine. 175:1992;1181-1194.
81. Shames B.D., Meldrum D.R., Selzman C.H., Pulido E.J., Cain B.S., Banerjee A., Harken A.H., Meng X. Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin. American Journal of Physiology. 275:1998;H1084-H1091.
82. Shinohara K., Shoji T., Emoto M., Tahara H., Koyama H., Ishimura E., Miki T., Tabata T., Nishizawa Y. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. Journal of American Society of Nephrology. 13:2002;1894-1900.
83. Simmons P.S., Miles J.M., Gerich J.E., Haymond M.W. Increased proteolysis: An effect of increases in plasma cortisol within the physiologic range. Journal of Clinical Investigation. 73:1984;412-420.
84. Solomon V., Goldberg A.L. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. Journal of Biological Chemistry. 271:1996;26690-26697.
85. Solomon V., Baracos V., Sarraf P., Goldberg A.L. Rates of ubiquitin conjugation increase when muscle atrophy, largely through activation of the N-end rule pathway. Proceedings of the National Academy of Sciences of the United States of America. 95:1998;12602-12607.
86. Sun X., Fischer D.R., Pritts T.A., Wray C.J., Hasselgren P.-O. Expression and binding activity of the glucocorticoid receptor are up-regulated in septic muscle. American Journal of Physiology - Regulatory Integrative and Comprehensive Physiology. 282:2002;R509-R518.
87. Tamura T., Osaka F., Kawamura Y., Higuti T., Ishida N., Nothwang H.-G., Tsurumi C., Tanaka K., Ichihara A. Isolation and characterization of α-type HC3 and β-type HC5 subunit genes of human proteasome. Journal of Molecular Biology. 224:1994;117-124.
88. Temparis S., Asensi M., Taillandier D., Aurousseau E., Larband D., Obled A., Béchet D., Ferrara M., Estrela J.M., Attaix D. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Research. 54:1994;5568-5573.
89. Thompson M.G., Thom A., Partridge K., Garden K., Campbell G.P., Calder G., Palmer R.M. Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C(2)C(12) myotubes by dexamethasone: Effect of the proteasome inhibitor MG-132. Journal of Cell Physiology. 181:1999;455-461.
90. Tiao G., Fagan J.M., Samuels N., James J.H., Hudson K., Lieberman M., Fischer J.E., Hasselgren P.-O. Sepsis stimulates non-lysosomal. Journal of Clinical Investigation. 94:1994;2255-2264.
91. Tiao G., Fagan J., Roegner V., Lieberman M., Wang J.-J., Fischer J.E., Hasselgren P.-O. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. Journal of Clinical Investigation. 97:1996;339-348.
92. Tiao G., Hobler S., Wang J.-J., Meyer T.A., Luchette F.A., Fischer J.E., Hasselgren P.-O. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. Journal of Clinical Investigation. 99:1997;163-168.
93. Tiao G., Lieberman M., Fischer J.E., Hasselgren P.-O. Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. American Journal of Physiology. 272:1997;R849-R856.
94. Tilignac T., Temparis S., Combaret L., Taillandier D., Pouch M.N., Cervek M., Cardenas D.M., Le Bricon T., Debiton E., Samuels S.E., Madelmont J.C., Attaix D. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis. Cancer Research. 62:2002;2771-2777.
95. Tisdale M.J. Wasting in cancer. Journal of Nutrition. 129:1999;243S-246S.
96. Tomas F.M., Munro H.N., Young V.R. Effects of glucocorticoid administration and the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N-methylhisitidine. Biochemistry Journal. 178:1979;139-146.
97. Vlach J., Garcia A., Jacque J.M., Rodriguez M.S., Michelson S., Virelizier J.L. Induction of Sp1 phosphorylation and NF-kappaB-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology. 208:1995;753-761.
98. Voges D., Zwickl P., Baumeister W. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annual Review of Biochemistry. 68:1999;1015-1068.
99. 2+-activated, and ubiquitin-proteasome proteolytic pathways. Journal of Clinical Investigation. 97:1996;1610-1617.
100. Wang L., Guang-Ju L., Wang J.-J., Hasselgren P-O. Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes. Shock. 10:1998;298-306.
101. Whitehouse A.S., Tisdale M.J. Down-regulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochemical and Biophysics Research and Communication. 285:2001;598-602.
102. Whitehouse A.S., Smith H.J., Drake J.L., Tisdale M.J. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Research. 61:2001;3604-3609.
103. Wiborg O., Pedersen M.S., Wind A., Berglund L.E., Marcker K.A., Vuust J. The human ubiquitin multigene family: Some genes contain multiple directly repeated ubiquitin coding sequences. EMBO Journal. 4:1985;755-759.
104. Williams A., Sun X., Fischer J.E., Hasselgren P.-O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery. 126:1999;744-749.
105. Wing S.S., Banville D. 14-kDa Ubiquitin-conjugating enzyme: Structure of the rat gene and regulation upon fasting and by insulin. American Journal of Physiology. 267:1994;E39-E48.
106. Wing S.S., Goldberg A.L. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. American Journal of Physiology. 264:1993;E668-E676.
107. Wing S.S., Haas A.L., Goldberg A.L. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochemistry Journal. 307:1995;639-645.
108. Woodrow G., Turney J.H. Cause of death in acute renal failure. Nephrology Dialysis Transplantation. 7:1992;230-234.
109. Wray C.J., Sun X., Gang G.I., Hasselgren P.-O. Dantrolene down-regulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle. Journal of Surgical Research. 104:2002;82-87.
110. Zamir O., Hasselgren P.-O., von Allmen D., Fischer J.E. The effect of interleukin-1α and the glucocorticoid receptor blocker RU38486 on total and myofibrillar protein breakdown in skeletal muscle. Journal of Surgical Research. 50:1991;579-583.
111. Zheng X.L., Matsubara S., Diao C., Hollenberg M.D., Wong N.C. Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1. Journal of Biological Chemistry. 276:2001;13822-13829.